Latest News
Wednesday preview: Fed policy meeting in the spotlight
All eyes on Wednesday will be on the US central bank as policymakers at the Federal Reserve meet to decide on rates.
US close: Dow Jones and S&P 500 retreat from fresh record highs
Wall Street stocks closed mostly lower on Tuesday, with the Dow Jones and S&P 500 retreating from the fresh record highs reached in the previous session.
Europe close: Stocks extend gains ahead of Fed on reopening hopes
European stocks continued pushing ahead on Tuesday as Wall Street rallied overnight on hopes of an economic recovery and a $1. 9trn US stimulus package.
FTSE 250 movers: Investors eye real estate amid reopening hopes, Cineworld and Just Group pop higher
Investors had their eye on shares of real estate firms on Tuesday, amid hopes for the reopening of the UK economy and a smattering of news around the sector.
London close: Stocks finish firmer ahead of Fed, BoE decisions
London stocks managed a positive finish on Tuesday, as the pound was mixed against its major trading pairs.
Broker tips: AstraZeneca, B&M, Ultra Electronics
Jefferies upgraded its stance on shares of AstraZeneca to 'buy' from 'hold' on Tuesday saying the pharmaceuticals company’s impressive revenue and profit trajectory is compelling relative to EU peers, with improving quality of earnings and cash flow generation set to ease concerns.
Director dealings: Intertek CEO ups stake
Intertek Group revealed on Tuesday that chief executive André Lacroix had acquired 10,000 ordinary shares in the FTSE 100-listed assurance firm.
Conroy Gold raises £2.25m to strengthen balance sheet
Ireland and Finland-focussed exploration and development company Conroy Gold announced a £2. 25m financing on Tuesday, to strengthen its balance sheet and working capital position.
Helium One begins seismic data acquisition at Rukwa
Helium One announced the start of seismic data acquisition, with the mobilisation of vibroseis trucks and geophones to its wholly-owned Rukwa Project in Tanzania, on Tuesday.
FTSE 100 movers: AstraZeneca rallies; NatWest in the red
London’s FTSE 100 was up 0. 6% at 6,793. 00 in afternoon trade on Tuesday.
US open: Stocks mixed as Fed kicks off March policy meeting
Wall Street trading began on a mixed note on Tuesday after the Dow Jones and S&P 500 both closed at new record highs in the previous session.
Inflation takes over from Covid as biggest tail risk for investors - BofA
Covid-19 is no longer seen as the biggest risk to equity markets, according to the latest Bank of America Fund Manager Survey, with inflation and taper tantrums now bigger concerns.
Lexington expands exploration rights at Jones-Keystone-Loflin
Carolinas-focussed exploration and development company Lexington Gold has expanded its mineral exploration rights at the Jones-Keystone-Loflin (JKL) Project in North Carolina, it announced on Tuesday.
Volvere revenues rise as it turns around food investments
Food-focussed turnaround investment company Volvere said it expected to report revenue from continuing operations of around £30. 81m for 2020 on Tuesday, which would be an improvement from the £23. 04m recorded in 2019.
eToro going public by combining with Nasdaq-listed SPAC
Online-focused multi-asset investment platform eToro is set to become publicly traded, it announced on Tuesday, by combining with the Nasdaq-listed special purpose acquisition vehicle FinTech Acquisition Corp V.
Pent-up demand sees profits surge at ScS
ScS Group reported a surge in profits on Tuesday after pent-up demand post-lockdown boosted demand for home furnishings.
US pre-open: Stocks in the green after Dow Jones and S&P 500 close at new highs
Wall Street futures were pointing to a positive open ahead of the bell on Tuesday after the Dow Jones and S&P 500 both closed at new record highs yesterday.
Challenging year pushes Costain deeper into the red
Costain called 2020 an "exceptionally challenging" year on Tuesday, after the infrastructure specialist tumbled to a near £100m loss.
Nokia to cut up to 10,000 jobs worldwide
Nokia is to cut up to 10,000 jobs as it looks to take €600m of costs out of the business, the Finnish telecoms firm announced on Tuesday.
'No indication' AstraZeneca's Covid-19 vaccine causes blood clots - EMA
The European Medicines Agency said on Tuesday there is "no indication" that AstraZeneca’s Covid-19 vaccine causes blood clots.